- Home
- ULBI vs HRTX Comparison
ULBI vs HRTX Comparison
Compare ULBI & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ULBI | HRTX |
|---|---|---|
| Founded | 1990 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 102.1M | 90.1M |
| IPO Year | 1995 | 2007 |
Fundamental Metrics
Financial Performance| Metric | ULBI | HRTX |
|---|---|---|
| Price | $5.65 | $0.32 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.50 |
| AVG Volume (30 Days) | 33.7K | ★ 2.2M |
| Earning Date | 05-12-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 13.00 | N/A |
| Revenue | ★ $191,159,000.00 | $154,904,000.00 |
| Revenue This Year | $20.00 | $15.28 |
| Revenue Next Year | N/A | $20.29 |
| P/E Ratio | $0.43 | ★ N/A |
| Revenue Growth | ★ 16.24 | 7.36 |
| 52 Week Low | $4.90 | $0.30 |
| 52 Week High | $8.25 | $1.58 |
Technical Indicators
Market Signals| Indicator | ULBI | HRTX |
|---|---|---|
| Relative Strength Index (RSI) | 32.20 | 40.13 |
| Support Level | $5.54 | $0.30 |
| Resistance Level | $5.66 | $0.34 |
| Average True Range (ATR) | 0.26 | 0.02 |
| MACD | -0.14 | 0.01 |
| Stochastic Oscillator | 12.57 | 41.64 |
Price Performance
Historical ComparisonAbout ULBI Ultralife Corporation
Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company also designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.